Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 17/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 15/20 | 0.51 |
| ▸ | MEN1 | O00255 | 6/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.51 |
| ▸ | CASP1 | P29466 | 13/20 | 0.48 |
| ▸ | CASP7 | P55210 | 10/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 11/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 9/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 9/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5153474 | 0.89 | TP53 (0.45) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL5153106 | 0.82 | SMN1; SMN2 (0.44) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL5152247 | 0.80 | USP2 (0.48) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL5156664 | 0.76 | ADORA2A (0.55) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL4507905 | 0.73 | ADORA2A (0.46) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL5155804 | 0.72 | CYP1A2 (0.52) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL5152091 | 0.72 | CYP1A2 (0.52) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL4524133 | 0.70 | ADORA2A (0.69) | ADORA2AADORA1 | |
| SCHEMBL5336593 | 0.70 | CYP1A2 (0.50) | USP2CYP3A4MEN1KMT2ABRCA1 | |
| SCHEMBL4532246 | 0.69 | ADORA2A (0.64) | ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070225304-A1 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | PHARMACOPEIA DRUG DISCOVERY, INC. (US) | 2007-09-27 | — | — | US | disclosed |
| WO-2007030438-A2 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | PHARMACOPEIA, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225304-A1 | AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES | TPMT, ADORA2A, ENTPD5 | USP2 2651/4885CYP3A4 2471/4885MEN1 4507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.